Continuous interscalene analgesia with ropivacaine 2 mg/ml after major shoulder surgery

Anesthesiology

Volumn 98, Issue 1, 2003, Pages 143-150

  Ekatodramis, Georgios ^a   Borgeat, Alain ^a   Huledal, Gunilla ^b   Jeppsson, Lennart ^b   Westman, Lars ^b   Sjövall, Jan ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2,6 PIPECOLOXYLIDIDE; DRUG METABOLITE; LOCAL ANESTHETIC AGENT; ROPIVACAINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CATHETER INFECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG INFUSION; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG TISSUE LEVEL; FEMALE; HUMAN; INHALATION ANESTHESIA; MAJOR SURGERY; MALE; MAXIMUM ALLOWABLE CONCENTRATION; NAUSEA; PAIN ASSESSMENT; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHOULDER; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; AGED; AMIDES; ANALGESIA; ANESTHETICS, LOCAL; BIOTRANSFORMATION; BRACHIAL PLEXUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALF-LIFE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; NERVE BLOCK; ORTHOPEDIC PROCEDURES; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; SHOULDER; SHOULDER PAIN;

EID: 0037219981     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200301000-00023     Document Type: Article

References (19)

1. Tuominen M, Pitkanen M, Rosenberg PH: Postoperative pain relief and bupivacaine plasma levels during continuous interscalene brachial plexus block. Acta Anaesthesiol Scand 1987; 31:276-8
2. Borgeat A, Schäppi B, Biasca N, Gerber C: Patient-controlled analgesia after major shoulder surgery: Patient-controlled interscalene analgesia versus patient-controlled analgesia. Anesthesiology 1997; 87:1343-7
3. Borgeat A, Tewes E, Biasca N, Gerber C: Patient-controlled interscalene analgesia with ropivacaine after major shoulder surgery: PCIA vs. PCA. Br J Anesth 1998; 81:603-5
4. McClellan KJ, Faulds D: Ropivacaine: An update of its use in regional anaesthesia. Drugs 2000; 60:1065-93
5. Knudsen K, Beckman Suurküla M, Blomberg S, Sjövall J, Edvardsson N: Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth 1997; 78:507-14
6. Scott DB, Lee A, Fagan D, Bowler GM, Bloomfield P, Lundh R: Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989; 69:563-9
7. Engman M, Neidenström P, Norsten-Höög C, Wiklund SJ, Bondesson U, Arvidsson T: Determination of ropivacaine and (2H3)ropivacaine in biological samples by gas chromatography with nitrogen-phosphorous detection or mass spectrometry. J Chromatogr 1998; 709:57-67
8. Emanuelsson BM, Persson J, Sandin S, Alm C, Gustafsson LL: Intraindividual and interindividual variability in the disposition of the local anesthetic ropivacaine in healthy subjects. Ther Drug Monit 1997; 19:126-31
9. Emanuelsson BM, Zaric D, Nydahl PA, Axelsson KH: Pharmacokinetics of ropivacaine and bupivacaine during 21 hours of continuous epidural infusion in healthy male volunteers. Anesth Analg 1995; 81:1163-8
10. Erichsen CJ, Sjövall J, Kehlet H, Hedlund C, Arvidsson T: Pharmacokinetics and analgesic effect of ropivacaine during continuous epidural infusion for postoperative pain relief. Anesthesiology 1996; 84:834-42
11. Convery PN, Milligan KR, Quinn P, Sjövall J, Gustafsson U: Efficacy and uptake of ropivacaine and bupivacaine after single intra-articular injection in the knee joint. Br J Anaesth 2001; 87:570-6
12. Aronsen KF, Ekelund G, Kindmark CO, Laurell CB: Sequential changes of plasma proteins after surgical trauma. Scand J Clin Lab Invest 1972; 29(suppl)124:127-36
13. Wulf H, Winckler K, Maier C, Heinzow B: Pharmacokinetics and protein binding of bupivacaine in postoperative epidural analgesia. Acta Anaesthesiol Scand 1988; 32:530-4
14. Halldin MM, Bredberg E, Angelin B, Arvidsson T, Askemark Y, Elofsson S, Widman M: Metabolism and excretion of ropivacaine in humans. Drug Metab Dispos 1996; 24:962-8
15. Arlander E, Ekström G, Alm C, Carrillo JA, Bielenstein M, Böttiger Y, Bertilsson L, Gustafsson LL: Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: An interaction study with fluvoxamine and ketoconazole as in vivo inhibitors. Clin Pharmacol Ther 1998; 64:484-91
16. Burm AG, Stienstra R, Brouwer RP, Emanuelsson BM, Van Kleef JW: Epidural infusion of ropivacaine for postoperative analgesia after major orthopedic surgery: Pharmacokinetic evaluation. Anesthesiology 2000; 93:395-403
17. Halldin MM: Plasma Protein Binding of Pipecoloxylidide in Rats. Astra Report 802-LF-0417-01. April 20, 1998. Astra Pain Control AB, Södertälje, Sweden
18. Borgeat A, Kalberer F, Jacob H, Ruetsch YA, Gerber C: Patient-controlled analgesia with ropivacaine 0.2% versus bupivacaine 0.15% after major open shoulder surgery: The effects on hand motor function. Anesth Analg 2001; 92:218-23
19. Singelyn FJ, Seguy S, Gouverneur JM: Interscalene brachial plexus analgesia after open shoulder surgery: Continuous versus patient-controlled infusion. Anesth Analg 1999; 89:1216-20